Twist Bioscience
$188.05Change from previous close: −2.69%Absolute change: −$5.19
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $12.47B
- Enterprise value
- $11.73B
- Forward P/E
- -297.3
- Price/book
- 26.4
- Price/sales
- 28.9
- EV/EBITDA
- -101.8
- EV/revenue
- 27.2
Profitability and growth
- Gross margin
- 52.0%
- Operating margin
- -30.6%
- Net margin
- -31.7%
- ROE
- -29.6%
- ROA
- -13.1%
- Revenue growth (year over year)
- 23.2%
Financial health
- Total cash
- $166.84M
- Total debt
- $108.59M
- Debt/equity
- 0.24
- Current ratio
- 2.67
- Quick ratio
- 1.98
Dividends
- Payout ratio
- 0.0%
Analysts and estimates
- Average price target
- $112.08
- Median price target
- $115.00
- High price target
- $190.00
- Low price target
- $36.00
- Analysts with a price target
- 12
- Consensus
- Buy
- Forward EPS
- -$0.63
- EPS estimate, current year
- -$0.96
Shares and trading
- Beta
- 2.22
- Average volume
- 1.78M
- Shares outstanding
- 66.3M
- Float
- 61.97M
- Institutional ownership
- 117.0%
- Insider ownership
- 0.8%
- Short interest (% of float)
- 23.8%
- Short ratio (days)
- 7.74